CR2 and glaucoma: Complement C3 activation intersects the three pathways of complement activation, and one group assessed an AAV vector encoding a C3 inhibitor, CR2-Crry (AAV2-CR2-Crry), in the DBA/2J mouse model of glaucoma [24].